Skip to main content

Table 3 Cost of managing HAE episodes with icatibant (Euros)

From: Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain

 

Per episode

Nationwide per year

 

Variable

Strategy 1

Strategy 2

Savings

Strategy 1

Strategy 2

Savings

Savings (%)

Direct costs

1,272.42

1,182.62

89.80

5,783,612

5,375,455

408,157

7.06

Medical

1,264.71

1,181.31

83.40

5,748,578

5,369,480

379,098

6.59

   Icatibant

1,164.95

1,164.95

0.00

5,295,122

5,295,122

0

0.00

   Visits*

97.13

16.22

80.92

441,498

73,706

367,792

83.31

   Admissions

2.44

0.12

2.32

11,113

567

10,546

94.90

   Tracheotomy

0.19

0.02

0.17

845

84

760

90.00

Non-medical

7.71

1.31

6.39

35,034

5,975

29,059

82.95

    Transportation

7.71

1.31

6.39

35,034

5,975

29,059

82.95

Indirect costs

42.73

11.22

31.51

194,220

51,006

143,214

73.74

   Caretaker

13.54

4.81

8.73

61,535

21,844

39,691

64.50

   Labour loss

13.63

4.86

8.77

61,967

22,090

39,877

64.35

   Death

15.56

1.56

14.00

70,718

7,072

63,646

90.00

Social cost

1,315.14

1,193.84

121.30

5,977,832

5,426,461

551,371

9.22

  1. Strategy 1= Health professional-administration only; Strategy 2= Self-administration also available.
  2. *Includes visits to hospital emergency rooms, primary care centres emergency rooms, and to HAE specialist offices.